China NT Pharma Group Company Limited (01011) released its Monthly Return for the period ended 31 January 2026. The company’s total authorised share capital stood at USD 50,100, comprising 62,592,500,000 ordinary shares and 32,500,000 preference shares, both with a par value of USD 0.0000008. The aggregate authorised capital for ordinary shares was USD 50,074, and the preference shares totalled USD 26.

The total number of issued ordinary shares remained at 674,246,015, with no changes from the previous month. The company further confirmed compliance with the relevant public float requirement, specifying a 25% threshold of the total issued shares in public hands under the applicable listing rules.